Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014. Alvaro Pascual-Leone, HMS professor of neurology at Beth Israel Deaconess Medical Center, is leading a trial of the system.
News & Research
